Discover
The Orange Pill Podcast
The Orange Pill Podcast
Author: KGK Science
Subscribed: 2Played: 1Subscribe
Share
Copyright Š2025 KGK Science. All rights reserved.
Description
The Orange Pill Podcast đď¸
Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers:
âď¸ Breaking industry news and trends
âď¸ Educational insights and practical takeaways
âď¸ Discussions on cutting-edge research
âď¸ Landmark cases and notable events shaping the field
Join us as we bridge the gap between science, regulation, and everyday impact.
Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers:
âď¸ Breaking industry news and trends
âď¸ Educational insights and practical takeaways
âď¸ Discussions on cutting-edge research
âď¸ Landmark cases and notable events shaping the field
Join us as we bridge the gap between science, regulation, and everyday impact.
83Â Episodes
Reverse
For nearly a century, U.S. cosmetic regulation remained largely unchanged. That era officially ended with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), and now, the FDA is racing to catch up.
In Episode 83 of the Orange Pill Podcast, we unpack five major regulatory developments that signal a fundamental shift in how cosmetics are tested, labeled, and enforced in the United States.
Drawing from recent FDA actions and the Fall 2024 Unified Agenda, this episode explores:
⢠The FDAâs long-awaited move to mandate asbestos testing in talc products
⢠Why the agency is using a broader mineral definition to future-proof safety
⢠How fragrance âtrade secretsâ are ending with allergen disclosure rules
⢠The delayed but historic push toward a formaldehyde ban in hair products
⢠How the 2025 administrative transition has triggered a widespread regulatory freeze impacting MoCRA timelines
We discuss what these shifts mean for brands, manufacturers, regulatory teams, and consumers, and why companies should already be preparing their quality systems, documentation, and compliance strategies.
This episode isnât just about beauty. Itâs about accountability, transparency, and the future of consumer protection.
Â
The world is facing a neurological emergency. Dementia cases are projected to nearly triple by 2050, and despite decades of pharmaceutical research, effective, scalable solutions remain limited. This has pushed scientists to look beyond single-target drugs and toward food-based, systems-level interventions.
In Episode 82 of the Orange Pill Podcast, we explore why red beetroot is emerging as a serious scientific contender in the fight against what many researchers now call âType 3 Diabetesâ , the metabolic and insulin-resistant decline of the aging brain.
This episode unpacks groundbreaking research showing that beetrootâs benefits are not just nutritional, but neurological, vascular, and microbiome-dependent.
It also reframes brain health as a mouth-to-microbe-to-mitochondria conversation, and positions beetroot as a powerful example of how whole foods may influence neurodegeneration.
đ§ Listen to Episode 82 to discover why the future of cognitive resilience may begin not in the pharmacy, but in the produce aisle.
Colostrum, often called âliquid goldâ, has taken over longevity circles, biohacking podcasts, and premium supplement shelves. Marketed for everything from gut health to immune resilience and anti-aging, its popularity has surged faster than human clinical research.
In Episode 81 of the Orange Pill Podcast, we break down a newly published randomized, double-blind, placebo-controlled clinical trial from the Journal of Functional Foods that finally puts colostrum to the test in adults aged 55â70.
This episode explores what the data actually shows:
⢠Colostrumâs antibodies survive digestion and remain bioactive in the gut
⢠IGF-1 levels increased while age-related decline continued in the placebo group
⢠Participants saw reduced leg fat accumulation, suggesting metabolic preservation
⢠Markers pointed toward immune priming, not just passive immunity
⢠No short-term changes in bone density or cognition - a reality check on timelines
⢠A strong safety profile, with mostly mild, short-term digestive effects
Rather than a miracle cure, this study positions colostrum as a biologically active, patience-requiring intervention for immune and metabolic resilience in aging populations.
Neuropathic pain affects up to 18% of the global population and remains one of the most difficult chronic conditions to manage. Existing therapies often come with serious trade-offs such as sedation, dependency, and limited long-term relief, highlighting the urgent need for safer, more effective solutions.
In Episode 80 of the Orange Pill Podcast, we explore fascinating new preclinical research on geraniin, a naturally occurring compound found in plants like the peel of the rambutan fruit. The study suggests this compound doesnât just blunt pain signals, it may actually help damaged nerves function better.
Rather than acting as a single-target âpainkiller,â geraniin demonstrated a multi-pathway approach, addressing several biological drivers of nerve damage at once.
This research highlights the growing potential of complex natural compounds in tackling equally complex chronic conditions.
When you scan a food or supplement label, you might assume youâre seeing the most credible health information available. But what if some of the most authoritative, government-backed science is being kept off labels altogether?
In this episode of the Orange Pill Podcast, we unpack a new legal battle thatâs putting the FDAâs regulatory authority, free speech, and consumer rights under the spotlight. At the center of the case is a surprising contradiction: claims drawn directly from research published by the NIH, CDC, and other federal health agencies are being blocked by the FDA from appearing on product labels.
We explore:
⢠Why the FDA is preventing companies from sharing government-authored health findings
⢠How a 1997 law was designed to allow these claims and why critics say the FDA overrode Congress
⢠Why this case is being framed as a First Amendment issue, not just a regulatory one
⢠How a recent Supreme Court ruling could dramatically shift the balance of power
⢠What this fight means for scientific transparency and informed consumer choice
This episode isnât just about supplements. Itâs about who gets to decide what health information reaches the public and whether consumers are being protected or restricted.
More than one in four adults struggle to fall or stay asleep and while prescription sleep aids can help, they often come with side effects like grogginess, confusion, and memory impairment. Thatâs why researchers are increasingly searching for safer, evidence-based alternatives.
In this episode of the Orange Pill Podcast, we dive into a fascinating new triple-blind, placebo-controlled clinical trial published in Food Science & Nutrition that explored a standardized Corn Leaf Extract (CLE) as a natural sleep aid.
The results were striking.
We also explore one of the most intriguing findings of all: while objective brain data showed clear improvements over placebo, both groups felt their sleep had improved - highlighting the powerful difference between perception and measurable physiology.
This episode unpacks what this means for the future of natural sleep solutions and why objective clinical tools matter more than ever.
As dementia rates climb worldwide, projected to reach nearly 153 million cases by 2050, diet has emerged as one of the most important modifiable risk factors. But the science behind âbrain foodâ is far more complex than simply avoiding certain foods or adding others.
In this final episode of the year, the Orange Pill Podcast takes a deep dive into three surprising scientific findings that are reshaping how we think about diet and long-term cognitive health.
In Episode 77, we explore:
⢠Why the inflammatory potential of your overall diet matters more than individual foods
⢠How a massive 25-year study found high-fat cheese and cream were associated with lower dementia risk
⢠Why âhealthy eatingâ isnât one-size-fits-all and how race, genetics, and vascular health change outcomes
Drawing from large population studies including the Framingham Heart Study, MalmĂś Diet and Cancer cohort, and the Chicago Health and Aging Project, this episode challenges simplistic narratives and points toward a more personalized, inflammation-aware approach to brain health.
As we wrap up the year, this episode invites a more thoughtful question:
What does a truly brain-healthy diet look like for you?
Dietary supplements promise strength, focus, resilience, and disease prevention, but how well do we truly understand their benefits and risks?
In Episode 76 of the Orange Pill Podcast, we take a deep dive into one of the most comprehensive investigations of supplement use ever conducted: a Department of Defenseâcommissioned report by the Institute of Medicine examining dietary supplement use among U.S. military personnel- one of the worldâs most physically and mentally stressed populations.
This episode unpacks the most important and surprising findings, including:
⢠Why supplements are regulated as foods, not drugs, and what that really means for safety
⢠Why âsold on baseâ does not mean âmilitary-approvedâ
⢠The proven benefits and real limitations of caffeine as a performance aid
⢠The striking gap between supplement use and disclosure to healthcare providers
⢠Why more clinical research is urgently needed in high-stress populations like the military
We also address common misconceptions about FDA oversight, dietary supplement GMPs, and adverse event reporting, revealing a regulatory framework that is often misunderstood by the public.
This episode offers critical insights not just for service members, but for consumers, healthcare providers, regulators, and supplement brands alike.
Weight-loss science is having a renaissance. While todayâs blockbuster drugs curb appetite by acting on the brain, a groundbreaking new discovery points to an entirely different frontier - one inside the gut.
In Episode 75 of the Orange Pill Podcast, we explore a remarkable molecule produced not by our bodies, but by our gut bacteria. Itâs called Desaminotyrosine (DAT), and new research suggests it could help the body burn fat faster, cleaner, and without ever decreasing appetite.
This discovery points toward a future where weight management isn't about eating less, but about helping your gut bacteria work smarter.
Listen to Episode 75 to learn how your microbiome could become one of the most powerful tools in metabolic health.
In a world where stress is constant and focus feels fleeting, many people turn to L-theanine, the calming amino acid found in green tea. But new clinical research on a purified form, AlphaWaveÂŽ L-Theanine, reveals a story far more sophisticated than the usual ârelaxation without drowsinessâ claim.
In Episode 74 of the Orange Pill Podcast, we unpack four surprising scientific discoveries that challenge long-held assumptions about L-theanine and how it affects the brain:
1ď¸âŁ It creates a measurable state of ârelaxed wakefulness.â
A single dose significantly boosts alpha brainwaves - the same patterns seen in meditation.
2ď¸âŁ It sharpens attention, not just calm.
In a 28-day clinical trial, participants taking AlphaWaveÂŽ improved their cognitive reaction speed faster and more consistently than placebo.
3ď¸âŁ It may improve sleep efficiency, not sleep duration.
Surprisingly, participants slept less but maintained strong next-day cognitive performance - suggesting more restorative sleep cycles.
4ď¸âŁ Your mindset matters too.
The study also showed that placebo participants reported lower stress, highlighting the powerful interplay between biology and belief.
This episode paints a new picture of L-theanine as a cognitive state modulator, not just a calming agent - one that helps the brain filter out stress ânoiseâ while elevating focus, clarity, and restorative rest.
đ§ Tune in to Episode 74 to explore the science behind stress, focus, and the future of nootropics.
The global protein crisis is here and science may have just delivered an unexpected solution: a gene-edited fungus that uses 44% less sugar, grows 88% faster, produces clean, complete protein, and still tastes remarkably like meat.
In this episode of the Orange Pill Podcast, we dive into groundbreaking new research on Fusarium venenatum, the same fungus behind mycoprotein, and explore how a precise, âscarlessâ CRISPR edit is reshaping the sustainability, nutrition, and future potential of alternative proteins.
From environmental impact to regulatory acceptance to consumer perception, this episode explores how fungi, and gene-edited foods more broadly, may redefine the future of protein on a warming planet.
The supplement aisle is packed with promises - better sleep, stronger immunity, improved focus - but how much of it is truly backed by science?
In this episode of the Orange Pill Podcast, we go beyond the marketing noise to explore five surprising truths decades of research have revealed about dietary supplements. From the downfall of once-hyped herbal remedies to the rise of personalized nutrition and the untapped influence of the gut microbiome, this episode challenges the outdated âone nutrient, one solutionâ mindset.
We uncover:
⢠Why some of the biggest studies on popular herbs failed
⢠Why âone-size-fits-allâ nutrition simply doesnât work
⢠How your gut microbes change how supplements behave
⢠The real story behind industry-funded research
⢠How nutrition science has evolved from deficiency prevention to health optimization
This is a must-listen for anyone who wants to make smarter, science-driven choices about their health and understand whatâs truly shaping the future of supplements.
Most of us trust that the foods we buy are safe and clearly labeled, but a new bill in Washington may quietly change the rules.
In this episode, we break down the âBetter Food Disclosure Act of 2025â, a bill introduced by Senator Roger Marshall that promises to strengthen transparency in the food system. At first glance, it looks like progress. But beneath the surface are four major structural issues that critics warn could actually weaken food safety regulation, not strengthen it.
We explore:
⢠How new food chemicals could be approved by default if the FDA runs out of time
⢠Why removing unsafe ingredients may become harder than ever
⢠The massive, unfunded workload the bill hands to an already overextended FDA
⢠How âdisclosureâ doesnât necessarily mean public transparency
With insights from the Center for Science in the Public Interest (CSPI), we uncover why some experts are calling this bill a legislative âlobster trapâ- easy for chemicals to enter the food supply, nearly impossible to remove them once inside.
Join us for Episode 71 as we unpack the fine print and help you understand what this bill could mean for public health and the future of food safety in the U.S.
That âClinically Provenâ label on your favorite supplement might not mean what you think. In this episode, we peel back the curtain on the world of health product research, where not all studies are created equal.
Join us as we explore five surprising truths about how health products are tested, from the misuse of patient-reported outcomes (PROs) to the hidden pitfalls of fully virtual trials. Youâll learn why the FDA is cracking down on vague âquality of lifeâ claims, how some trials rely on predicted margins instead of actual data, and why the future of clinical research lies in hybrid trial design, combining scientific rigor with participant convenience.
If youâre a supplement brand, formulator, or regulatory professional, this is an episode you donât want to miss.
The U.S. dietary supplement industry is thriving, but beneath the surface of growth lies a rising wave of class action litigation thatâs reshaping how brands think about packaging, marketing, and labeling.
In this episode of the Orange Pill Podcast, we uncover three emerging legal trends every supplement company should know:
1ď¸âŁ Slack-fill lawsuits - why âempty spaceâ in your packaging could cost millions.
2ď¸âŁ Protein spiking claims - the controversy shaking up the protein powder market.
3ď¸âŁ âMade in the USAâ pitfalls - how global sourcing could land domestic brands in legal hot water.
Â
Compliance with FDA rules is no longer enough. Learn how to protect your brand reputation and stay ahead of these new legal risks reshaping the supplement industry.
The legalization of cannabis has created a billion-dollar problem that technology is only now catching up to solve: how can we accurately measure impairment, not just use?
In this episode of the Orange Pill Podcast, we dive into groundbreaking research featuring the CognalyzerÂŽ- a novel EEG-based device that measures brainwave alterations to detect cannabis impairment directly. Unlike traditional methods such as saliva or blood tests, which can penalize sober individuals long after consumption, this technology focuses on what truly matters: the brainâs current state.
This episode challenges assumptions, highlights the science, and explores how objective data can pave the way for smarter regulation and safer consumption.
Aggression, from playground fights to serious violence, has long challenged families and communities alike. But what if one of the simplest, safest, and most effective tools for reducing aggression has been sitting on our dinner plates all along?
In this episode, we explore a groundbreaking new meta-analysis spanning nearly 30 years of research that reveals how omega-3 supplementation, the same fatty acids found in fish oil, can reduce aggression by up to 30%.
Join us as we unpack:
The evidence behind 29 randomized controlled trials
How omega-3 helps regulate both âhotâ and âcoldâ aggression
Why experts are calling for its immediate implementation
And how this simple nutritional step could transform mental health strategies
Tune in to discover how a small dietary change could make a big difference in behavior, brain health, and community well-being.
We all try to eat better, loading up on antioxidant-rich berries, turmeric, and green veggies, but hereâs the surprising truth: many of those âsuper-nutrientsâ never make it past your digestive system.
In this episode of the Orange Pill Podcast, we explore how nanotechnology is rewriting the rules of nutrition. From nanoencapsulation that protects fragile compounds like curcumin and quercetin, to upcycling food waste into potent new supplements, science is finally addressing the âbioavailability bottleneck.â
But with every breakthrough comes new questions, about safety, regulation, and the fine line between innovation and over-engineering our food. Are we entering an era of âprogrammed nutrition,â and what will it mean for the future of health and wellness?
Fermented foods like cheese, wine, and cured meats are celebrated for their complex flavors, but they may harbor hidden risks. In this episode of The Orange Pill Podcast, we explore the world of biogenic amines (BAs), naturally occurring compounds that can pose health hazards despite their delicious origins. From the âcheese effectâ of tyramine to toxic synergy among multiple amines, we discuss why regulating histamine alone isnât enough. Learn why food safety experts are calling for clear specifications for biogenic amines in foods and dietary supplements, and how manufacturers can proactively protect consumers.
In Episode 64, we continue to unpack the regulatory evolution of cannabis and cannabidiol (CBD) in Canada (continuation of Episode 44) and whatâs next for the industry. From the Cannabis Act to proposed pathways that could finally allow CBD Natural Health Products (NHPs) to be sold without prescriptions, this episode dives deep into how Health Canadaâs changing stance could reshape accessibility, innovation, and economic opportunity.Â



